Mission statement · Company scope
“Our mission is to use our proprietary Alpha DaRT technology to transform the treatment of solid tumors and broaden the potential scope of local radiotherapy delivery across multiple clinical settings.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary) · Impact
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Technical
- Length
- 30 words · reading grade 18.9
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.75
- Record
- st_fad9eeb9933668a6
- Classification confidence
- 0.77
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-09 · sec_sentence · 20-F · accession 0001213900-26-025174
View filing ↗0 to compareCompare